COSTA MESA, Calif.--(BUSINESS WIRE)--VivoScript, Inc., a biotech company commercializing the In Vivo cell Reprogramming (IVR) technology platform, announced today that Eric H. Davidson, PhD, has joined its Scientific Advisory Board (SAB).
COSTA MESA, Calif.--(BUSINESS WIRE)--VivoScript, Inc., a biotech company commercializing the In Vivo cell Reprogramming (IVR) technology platform, announced today that Eric H. Davidson, PhD, has joined its Scientific Advisory Board (SAB).
